Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436. 1993

C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
Sanofi-Pharma Research Centre, Brussels, Belgium.

[3H]SR 47436, a selective and potent novel non-peptide antagonist of angiotensin receptors, was used to characterize the cardiac angiotensin AT1 receptors. In neonatal rat heart cells, Scatchard analysis showed a single class of high affinity binding sites (Kd = 0.24 nM, Bmax = 28 fmol/mg protein). The binding was saturable, reversible and prevented by angiotensin II and the AT1 subtype receptor antagonist DuP 753 whilst unaffected by the AT2 receptor antagonist PD123177. In the same cells, angiotensin II induced a twofold increase in the intracellular free Ca2+ concentration ([Ca2+]i), with a half-maximal effect (EC50) at 14 nM. This increase was prevented by SR 47436 (IC50 = 1.03 nM) and by the AT1 receptor antagonist DuP 753, but at higher concentrations (IC50 = 15.6 nM) and was unaffected by PD123177. These data directly demonstrate the presence of cardiac AT1 receptors in rat neonatal cardiomyocytes and confirm the involvement of AT1 receptors in cardiac Ca2+ homeostasis.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D000077405 Irbesartan A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease. 2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one,Aprovel,Avapro,BMS 186295,BMS-186295,Karvea,SR 47436,SR-47436,SR47436

Related Publications

C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
May 1993, The Journal of pharmacology and experimental therapeutics,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
November 1993, Journal of hypertension,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
November 1994, European journal of pharmacology,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
July 2005, Regulatory peptides,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
July 2003, Endocrinology,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
March 1994, European journal of pharmacology,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
January 1994, British journal of pharmacology,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
December 2003, Clinical and experimental pharmacology & physiology,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
November 1995, Circulation research,
C Delisée, and P Schaeffer, and C Cazaubon, and P Chatelain
December 1992, American journal of hypertension,
Copied contents to your clipboard!